BBBernard C. Te Boekhorst

Bernard C. Te Boekhorst

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bernard C. Te Boekhorst has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Cees J. van Echteld

    Department of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands

    2 shared publications
  • Kees W. van de Kolk

    Department of Cardiology, University Medical Center Utrecht, Utrecht, Netherlands

    2 shared publications
  • Matthijs F. van Oosterhout

    Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands

    2 shared publications
  • Aryan Vink

    Department of Pathology , University Medical Center , Utrecht , The Netherlands

    1 shared publication
  • Dominique P. de Kleijn

    Experimental Cardiology Laboratory, Department of Cardiology , University Medical Center Utrecht , Heidelberglaan 100, Room G02.523 , 3584 CX Utrecht , The Netherlands 2 Interuniversity Cardiology Institute of the Netherlands (ICIN) , The Netherlands

    1 shared publication
  • Frans L. Moll

    Department of Vascular Surgery , University Medical Center , Utrecht , The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Molecular MRI of Inflammation in Atherosclerosis

    by Bernard C. Te Boekhorst, Geralda A. van Tilborg, Gustav J. Strijkers, Klaas Nicolay

    Inflammatory activity in atherosclerotic plaque is a risk factor for plaque rupture and atherothrombosis and may direct interventional therapy. Inflammatory activity can be evaluated at the (sub)cellular level using in vivo molecular MRI. This paper reviews recent progress in contrast-enhanced molecular MRI to visualize atherosclerotic plaque inflammation. Various MRI contrast agents, among others ultra-small particles of iron oxide, low-molecular-weight Gd-chelates, micelles, liposomes, and perfluorocarbon emulsions, have been used for in vivo visualization of various inflammation-related targets, such as macrophages, oxidized LDL, endothelial cell expression, plaque neovasculature, MMPs, apoptosis, and activated platelets/thrombus. An enzyme-activatable magnetic resonance contrast agent has been developed to study myeloperoxidase activity in inflamed plaques. Agents creating contrast based on the chemical exchange saturation transfer mechanism were used for thrombus imaging. Transfer of these molecular MRI techniques to the clinic will critically depend on the safety profiles of these newly developed magnetic resonance contrast agents.


  • Evaluation of multicontrast MRI including fat suppression and inversion recovery spin echo for identification of intra-plaque hemorrhage and lipid core in human carotid plaque using the mahalanobis distance measure

    by Bernard C. Te Boekhorst, Ronald van 'T Klooster, Sandra M. Bovens, Kees W. van de Kolk, Maarten J. Cramer, Matthijs F. van Oosterhout, Pieter. A. Doevendans, Rob J. van der Geest, Gerard Pasterkamp, Cees J. van Echteld

    Intra-plaque hemorrhage (IPH) and lipid core, characteristics of rupture prone carotid plaques, are often visualized in vivo with MRI using T1 weighted gradient and spin echo, respectively. Increasing magnetic field strength may help to identify IPH and lipid core better. As a proof of concept, automatic segmentation of plaque components was performed with the Mahalanobis distance (MD) measure derived from image contrast from multicontrast MR images including inversion recovery spin echo and T1 weighted gradient echo with fat suppression. After MRI of nine formaldehyde-fixated autopsy specimens, the MDs and Euclidean Distances between plaque component intensities were calculated for each MR weighting. The distances from the carotid bifurcation and the size and shape of calcification spots were used as landmarks for coregistration of MRI and histology. MD between collagen/cell-rich area and IPH was largest with inversion recovery spin echo (4.2/9.3, respectively), between collagen/cell-rich area/foam cells and lipid core with T1 weighted gradient echo with fat suppression (26.9/38.2/4.6, respectively). The accuracy of detection of IPH, cell-rich area, and collagen increased when the MD classifier was used compared with the Euclidean Distance classifier. The enhanced conspicuity of lipid core and IPH in human carotid artery plaque, using ex vivo T1 weighted gradient echo with fat suppression and inversion recovery spin echo MRI and MD classifiers, demands further in vivo evaluation in patients.


  • Open Access

    Molecular MRI of murine atherosclerotic plaque targeting NGAL: a protein associated with unstable human plaque characteristics

    by Bernard C. Te Boekhorst, Sandra M. Bovens, Willem E. Hellings, Petra H. van der Kraak, Kees W. van de Kolk, Aryan Vink, Frans L. Moll, Matthijs F. van Oosterhout, Jean P. de Vries, Pieter A. Doevendans, et al.

    Neutrophil gelatinase-associated lipocalin (NGAL) is an effector molecule of the innate immune system. One of its actions is the prolongation of matrix metalloproteinase-9 (MMP-9) activity by the formation of a degradation-resistant NGAL/MMP-9 complex. We studied NGAL in human atherosclerotic lesions and we examined whether NGAL could act as a target for molecular imaging of atherosclerotic plaques. Increased levels of NGAL and the NGAL/MMP-9 complex were associated with high lipid content, high number of macrophages, high interleukin-6 (IL-6) and IL-8 levels, and low smooth muscle cell content in human atherosclerotic lesions obtained during carotid endarterectomy (n= 122). Moreover, plaque levels of NGAL tended to be higher when intra-plaque haemorrhage (IPH) or luminal thrombus was present (n= 77) than without the presence of IPH or thrombus (n= 30). MMP-9 and -8 activities were strongly related to NGAL levels. The enhancement on magnetic resonance (MR) images of the abdominal aorta of ApoE−/−/eNOS−/− mice was observed at 72 h after injection of NGAL/24p3-targeted micelles. The specificity of these results was validated by histology, and co-localization of micelles, macrophages, and NGAL/24p3 was observed. NGAL is highly expressed in atheromatous human plaques and associated with increased MMP-9 activity. NGAL can be detected in murine atherosclerotic arteries using targeted high-resolution MR imaging. Therefore, we conclude that NGAL might serve as a novel imaging target for the detection of high-risk plaques.